Absorptive Capability of Japanese and European MNCs : Balance between Autonomy and Control of R&D Subsidiaries in the US by ARAI SEIKO
  
 
 
GRIPS Discussion Paper 16-18 
 
 
 
 
 
 Absorptive Capability of Japanese and European MNCs: Balance 
between Autonomy and Control of R&D Subsidiaries in the US 
           
 
 
 
 
Seiko Arai 
 
 
 
 
 
 
 
 
 
 
October 2016 
 
 
 
 
 
 
 
National Graduate Institute for Policy Studies 
7-22-1 Roppongi, Minato-ku, 
Tokyo, Japan 106-8677 
   
- 1 - 
 
 
 
ABSORPTIVE CAPABILITY OF JAPANESE AND EUROPEAN MNCs: BALANCE 
BETWEEN AUTONOMY AND CONTROL OF R&D SUBSIDIARIES IN THE US  
 
Seiko ARAI 
 
Uppsala University, Uppsala, Sweden 
National Graduate Institute for Policy Studies, Tokyo, Japan  
E-mail: s-arai@grips.ac.jp, seikoa2003@yahoo.com 
 
 
 
ABSTRACT 
 
This paper analyzes the capability of Japanese and European multinational companies 
(MNCs) to absorb technological knowledge from the United States through their R&D 
operation in the US. Employing the notion of “absorptive capacity”, this research defines the 
capability of a firm to absorb technological knowledge from abroad as “absorptive capability 
(AC),” and aims to examine the components of AC and their interrelationships using patent 
and sales data in the context of R&D management of Japanese and European MNCs at home 
and in the US. This paper also presents the taxonomies to show that a balance of autonomy 
and control is the key to increasing AC in the US and contributing to the US market sales by 
utilizing the home and host country technologies. 
 
INTRODUCTION 
 
In the past few decades, the world has seen the emergence of new technologies (e.g., 
information technology (IT) and biotechnology) that serve as key technologies across sectors. 
In response to this, the intensity of internationalization of R&D to exploit local knowledge has 
taken on increasing significance (Cantwell & Piscitello, 2000), while the internationalization 
of R&D has accelerated and is concentrated heavily in the “triad,” i.e., the United States, 
Japan and several countries of the European Union (EU), with the US as a center (Edler, 
Meyer-Krahmer, & Reger, 2002). There are clear differences in the degrees of international 
absorption of technological knowledge by country: Japan and Germany are lagging far behind 
the UK and Switzerland (Gambardella, Orsenigo, & Pammolli, 2000). At the same time, 
   
- 2 - 
 
 
considerable variances within countries were found, which suggests scope for managerial 
choice (Patel & Pavitt, 1997). 
The key concept of this study is “absorptive capability (AC),” defined as the ability to 
absorb technological knowledge from abroad. High technology-based multinational 
companies (MNCs) are increasingly seeking this capability to compete in the global markets, 
particularly where adopting cutting-edge technologies is crucial. This key construct relies on 
the notion of “absorptive capacity” introduced by Cohen and Levinthal (1990). The 
emergence of this “absorptive capacity” construct coincided with the development of the 
resource-based view of a firm (RBV) and the core competence of a firm, which made it one of 
the most important constructs in management research over the past decades (Lane, Koka, & 
Pathak, 2002). Zahra and George (2002), however, argue that existing studies do not always 
capture the rich theoretical arguments and the multidimensionality of the “absorptive 
capacity” construct. In particular, prior research devotes little attention to the multiple 
dimensions of “absorptive capacity” of MNCs to absorb knowledge across national borders, 
though national institutional differences between the home and host countries may add 
constraints on “absorptive capacity.”  
This study, therefore, aims to fill in these gaps and advance the understanding of the 
multiple dimensions of the capability of MNCs to absorb technological knowledge from 
abroad. I rely on the nexus of the literature on international management and the RBV and 
capabilities of a firm. On the one hand, a number of researchers point to the importance of 
combinative capability (Kogut & Zander, 1992), which implies a need for sufficient control 
over subsidiaries to combine their knowledge with knowledge at the headquarters (Ghoshal & 
Bartlett, 1990). On the other hand, prior studies argue that, for subsidiaries to acquire local 
knowledge and create a subsidiary-specific value, a certain level of autonomy is necessary so 
that they may be well embedded in their local network, and thus are able to explore local 
knowledge (Andersson, Forsgren, & Holm, 2002). Importantly, in coordinating the 
relationship between the headquarters and subsidiaries, a balance between the control and 
autonomy of a subsidiary is regarded as a critical factor in the enhancement and utilization of 
the knowledge of a subsidiary (e.g., Asakawa, 2001). But prior research using “absorptive 
capacity” in the analysis of international R&D management has made few attempts to 
investigate the effects of the conflicting needs of autonomy and control on the AC of MNCs.  
In light of these arguments, I build a model of AC including the dimensions 
(capabilities) concerning autonomy and control in the process of absorption of technological 
knowledge abroad. I seek to investigate: (1) What capabilities constitute the AC of MNCs to 
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absorb technological knowledge from abroad? (2) How are these capabilities related to each 
other? The model is examined empirically in the context of international R&D management. 
The research setting is Japanese and European multinational companies (MNCs) that operate 
R&D centers in the US in the electronics, automobile, pharmaceutical and chemical industries. 
I test several hypotheses concerning the relationships between the multiple dimensions 
(capabilities) of AC by using patent and sales data. My main findings are: (1) The 
combination of technological knowledge in the US with that in the home country has a 
significant positive effect on the utilization of US knowledge (increasing sales in the US); (2) 
The total amount of acquisition of technological knowledge in the US and the autonomy of 
US R&D subsidiaries both have a positive association with the utilization of US knowledge, 
but the association is not significant; (3) The autonomy and control of US subsidiaries may 
have mediating effects on the relationship between acquisition and utilization of US 
knowledge.  
 
LITERATURE REVIEW  
Absorptive capacity 
In contrast to the assumptions of neoclassical economic theory, the RBV seeks to 
understand why firms in the same industry are not identical, and allows for the possibility that 
critical resources may be immobile. The RBV, in other words, looks inside “the black box” 
and analyses the key success factors that underlie firm-specific advantages. The related 
“dynamic capabilities” literature emphasizes change and explains why and how some firms 
are capable of sustaining competitive advantage in rapidly changing business environments. 
To deal with these environments, managers are required to “integrate, build, and reconfigure 
internal and external competences” (Teece, Pisano, & Shuen, 1997). “Dynamic capabilities” 
are not merely skills of individuals, but organizational knowledge and processes embedded in 
firms, which may be organizational routines (Nelson & Winter, 1982) or learning mechanisms 
(Eisenhardt & Martin, 2000). Other researchers have used similar concepts, such as “core 
competences” (Prahalad & Hamel, 1990) and “firm-specific knowledge” (Pavitt, 1991).  
The emergence of the “absorptive capacity” construct, which provides a useful 
perspective for an analysis of the ability of firms to absorb technologies from abroad, 
coincided with the development of the RBV and its offshoot, the knowledge-based view of 
the firm. According to Cohen and Levinthal (1990), “absorptive capacity” is the ability of a 
firm to recognize the value of new external information, assimilate it, and apply it to 
commercial ends (p 128). They claim that this capacity is largely a function of the firm’s level 
   
- 4 - 
 
 
of prior related knowledge. In the analysis of “absorptive capacity” at different levels, they 
argue an organizational “absorptive capacity” depends not only on the sum of “absorptive 
capacity” of individual staff, but also on the network of individuals. It is important to note that 
the simple assimilation of external technologies without internal capability does not work. For 
high-technology based MNCs to catch up with technological progress in the world, 
assimilation of outside technology and the cultivation of in-house technological capabilities 
are essential twin processes (Cusumano & Elenkov, 1994). Prior research using the concept of 
“absorptive capacity” generally agrees that it is a multidimensional construct involving the 
ability to evaluate, assimilate, and apply external knowledge, or is a combination of effort and 
knowledge base (Zahra et al., 2002). 
Many studies have operationalized “absorptive capacity,” which has facilitated 
empirical investigation of what factors influence the ability of a country or an organization to 
acquire external knowledge. For example, investment in R&D resources (Cohen et al., 1990; 
Veugelers, 1997), “stickiness” of knowledge (Szulanski, 1996) and connectedness to the 
scientific community (Cockburn & Henderson, 1998) are shown as key factors that influence 
the “absorptive capacity” of firms. Zahra and George (2002), however, criticize that empirical 
work does not always capture the rich theoretical argument and the multidimensionality of the 
“absorptive capacity” construct. Only a few studies have attempted to expand and elaborate 
on the original definition of Cohen and Levinthal  (Lane, Koka, & Pathak, 2006). Prior 
research on international R&D activities devotes little attention to the multidimensionality of 
AC, nor does it elaborate on the original definition of “absorptive capacity” of MNCs as 
described below, while national institutional differences between the home and host countries 
may add constraints on a firm’s “absorptive capacity.” 
 
Absorptive capacity and international R&D 
Studies concerning “absorptive capacity” from the perspective of cross-border 
technology absorption have three levels of analysis: country, firm (organization) and people. 
They are centered primarily on the first two levels, and the two levels of these studies have 
distinct data sets and do not interact with each other, dealing with different sets of issues (Arai, 
2007). On the one hand, researchers often use public data such as technology trade 
(imports/exports),  patents or scientific papers to analyze it at a country or sector level, but 
they tend to leave a firm as a “black box” (Cantwell et al., 2000; Patel et al., 1997). On the 
other hand, previous work at a firm level usually relies on interview and questionnaire data 
and has been weak in the systematic analysis of AC. It has investigated mostly the issues of 
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motivation, location choices and roles of subsidiaries, and only a limited number of 
researchers have dealt with the coordination, control and communication problems of MNCs 
regarding R&D activities (Asakawa, 2001; de Mayer & Mizushima, 1989; Håkanson & 
Nobel, 1993; Håkanson & Zander, 1988; Nobel & Birkinshaw, 1998). Studies on technology 
sourcing of MNCs analyzes the acquisition of knowledge in the host countries (Almeida, 
1996; Frost, 2001), but it hardly touches upon the transfer and combination of the sourced 
knowledge within MNCs across national borders. Cross-border knowledge absorption and 
transfer within MNCs has become a subject of study only recently, and the capability of 
MNCs to manage it successfully has not been well investigated (Foss & Pedersen, 2004). 
This paper aims to fill in these gaps in current research and to contribute to the 
understanding of the multiple dimensions of AC of MNCs. I conceptualize various 
dimensions (capabilities) of AC and build a model in the next section. To assess the various 
capabilities with objective criteria to specify what capabilities AC consists of, I examine the 
model by relying on sales and patent data in the context of R&D management of Japanese and 
European MNCs at home and in the US.   
 
MODEL OF ANALYSIS 
Theoretical framework 
This paper pays special attention to the tension and the balance between autonomy and 
control in identifying multiple dimensions of AC: Autonomy facilitates subsidiaries’ 
exploration and assimilation of US technological knowledge, whereas control encourages the 
combination of US knowledge with knowledge in the home country.  
New combinations of resources are the key factors for firms’ survival. MNCs need to 
combine the knowledge of globally dispersed units to take advantage of their local expertise.  
Schumpeter was one of the first scholars to point out that innovation takes place “by carrying 
out new combinations” (Schumpeter, 1934, p65-66). Many other researchers have 
subsequently recognized the role of combination in innovation. For example, Kogut and 
Zander (1992) claim “an analysis of what firms can do must understand knowledge as 
embedded in the organizing principles by which people cooperate within organizations. ... 
(F)irms learn new skills by recombining their current capabilities” (p383). In the domain of 
technological management, Kodama (1992) used the term “technology fusion” and Iansiti 
(1995) named “technology integration” to describe the combination of technologies. These 
studies indicate a need for control by the headquarters over subsidiaries to facilitate the 
process of knowledge combination across borders in order to bring about more innovations.  
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Importantly prior studies of international management suggest that there is a tension 
between autonomy and control in terms of headquarters-subsidiary relationships (e.g., 
Asakawa, 2001).  On the one hand, a firm needs to give its subsidiaries enough autonomy to 
be embedded in the local network so as to explore and assimilate external knowledge 
worldwide. On the other hand, it is required to control its subsidiaries so as to combine their 
knowledge with the core knowledge, which usually exists in the country where the firm is 
headquartered. Yet there are many impediments especially to cross-border knowledge transfer 
and combination, and firms face various barriers such as linguistic, cultural and cognitive. 
To overcome this problem, MNCs must develop appropriate organizational mechanisms 
to share and combine knowledge across units worldwide. In developing these, MNCs need to 
adjust not only the organization and management of their US subsidiaries to those of their 
headquarters, but also their headquarters to their subsidiaries. However, because of the large 
institutional distance between the home and host countries, some adjustments may not be 
feasible. As a result, firms may need to exert more control over their subsidiaries to 
compensate for the organizational difference between the headquarters and subsidiaries, 
which can lower the level of autonomy and make lose an appropriate balance between 
autonomy and control. This dilemma between the competing requirements of autonomy and 
control in order to acquire and transfer local knowledge within a firm can be considered as a 
key issue concerning AC in the context of international R&D. 
 
Multiple dimensions of AC 
Based on these arguments, I propose four capabilities composing AC: AC consists of 
acquisition and utilization capabilities, and acquisition capability in turn comprises 
independence and combinative capabilities. Acquisition capability is defined as the ability of 
a firm to assimilate and acquire technological knowledge in the host country, and utilization 
capability is the ability to utilize and apply the knowledge to commercial ends. Independence 
capability centers on the exploration and assimilation of local knowledge in the US, whereas 
combinative capability enables the integration of host and home country knowledge of a firm. 
In what follows, I explain each capability in more detail. 
First, acquisition capability is defined as the ability to acquire foreign technological 
knowledge, comprising two subsets, combinative and independence capabilities. Acquisition 
capability not only involves assimilating, but also searching, recognizing, and evaluating 
external foreign knowledge before acquisition. Second, one of the two components of 
acquisition capability, independence capability, is defined as the ability to acquire 
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technological knowledge by foreign subsidiaries independently from the headquarters. 
Independence capability can be facilitated by the autonomy of US R&D subsidiaries, and it 
allows the subsidiaries to enjoy independence so that they may adopt organization and 
management styles that fit the local networks and assimilate more technological knowledge 
from them (Almeida, 1996; Andersson et al., 2002). In addition, especially in the case of 
R&D, autonomy of subsidiaries is essential in encouraging innovations, which rely to a large 
extent on the motivation of R&D staff.  
Third, combinative capability, another component of acquisition capability, is defined as 
the ability to integrate knowledge across national borders within a firm. Organizational 
absorptive capacity depends not only on the absorptive capacity of individual members of an 
organization, but also on transfer of knowledge across and within members (Cohen et al., 
1990). Researchers have emphasized the importance of combinative capability in different 
terms (e.g., Iansiti, 1995; Kodama, 1992; Kogut et al., 1992; Penrose, 1995; Teece et al., 
1997). To combine the existing technology resources of dispersed units in the processes of 
technology absorption abroad, it is crucial that the units within a MNC are under sufficient 
control so that it may integrate and make the most of its globally dispersed knowledge 
(Ghoshal et al., 1990). Fourth, utilization capability is considered as an ability to apply foreign 
technological knowledge to commercial ends. Utilization of external technologies is the 
process of exploitation by applying acquired and internalized technologies to final products or 
services in the market. The utilization capability is critical, given that the ultimate survival of 
a firm depends on the profits it can make. The next section presents hypotheses concerning 
the relationships between these multiple capabilities composing AC.  
 
HYPOTHESES 
Hypotheses on the influence of acquisition capability on utilization capability 
AC includes an ability not only to assimilate and recognize, but also to exploit external 
knowledge (Cohen et al., 1990). The first set of hypotheses deals with the effects of 
knowledge acquisition on utilizing technological knowledge for commercial ends. Firms that 
acquire more host country knowledge may have more opportunities and interest in utilizing it 
to increase their sales in the local market. For large high-technology based MNCs in business 
fields such as electronics/engineering, automotive, pharmaceutical and chemical sectors, the 
market is global, and in particular, the US markets are often a lead market to test their 
products. Therefore the primary objective of their US R&D operation is usually to contribute 
to product development both for the US and global markets. Thus the volume of acquisition of 
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US technological knowledge may be positively related to improving their sales in the US 
market. These arguments lead to the following hypothesis: 
 
Hypothesis 1. The more a firm has acquisition capability abroad, the higher the 
utilization capability of the firm in the local market is. 
 
Hypotheses on the influence of combinative and independence capabilities on 
utilization capability 
The next two hypotheses deal with the influence of the subsets of acquisition capability, 
combinative and independence capabilities, on utilization capability. Combinative capability 
serves as a key capability for innovation (Kogut et al., 1992; Schumpeter, 1934). Firms’ home 
bases provide dominant sources of competitiveness (Kogut, 1993; Porter, 1990), including 
technological capabilities (Patel & Vega, 1999). To develop novel products in internationally 
competitive markets, it is particularly critical that firms are able to combine their core 
technologies at home with foreign technologies that are not available in the home country. 
Thus firms that combine more knowledge in the US with home country knowledge may 
utilize US knowledge and have higher sales in the US market. The following hypothesis is 
therefore formulated: 
 
Hypothesis 2a. The more a firm has the combinative capability to integrate US 
technologies with those of the home country, the higher the utilization capability of the firm in 
the local market is. 
 
On the other hand, US subsidiaries with a higher degree of autonomy can respond to the 
local market more flexibly. If firms’ US R&D centers have been obtained as a result of 
acquisition of US firms, the R&D centers tend to be more independent from the headquarters 
and to collaborate more with other units of the US subsidiary, which are more focused on the 
US market. In addition, since the transmission cost of cross-border knowledge sharing is large, 
it may be that firms which share knowledge more with other units in the US than with the 
headquarters achieve more efficient use of US knowledge and perform better in the US 
market. For these reasons, firms with more independent overseas R&D operation may have 
more utilization capability to commercialize US knowledge in order to increase sales in the 
local market. Therefore, the following hypothesis is established: 
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Hypothesis 2b. The more a firm has the independence capability to acquire local 
technologies autonomously, the higher the utilization capability of the firm in the local market 
is. 
 
Hypotheses on the effect of independence capability on combinative capability  
The third set of hypotheses focuses on the relationship between combinative and 
independence capabilities. These two capabilities have competing characteristics: combinative 
capability is the ability to integrate US knowledge with home country knowledge, while 
independence capability is the ability to allow autonomy to US subsidiaries. There are two 
possible relationships between these two capabilities. One is that the high degree of US 
autonomy hinders the collaboration between the headquarters and US R&D centers. To 
facilitate such collaboration for cross-border knowledge combination, certain organizational 
mechanisms are necessary, but a high respect for the autonomy of US R&D centers may make 
it difficult to install such mechanisms. The other possible relationship is that more 
independent US R&D centers can have more valuable knowledge and induce more knowledge 
combination between the subsidiaries and headquarters. Autonomous R&D centers can be 
more embedded in the local science and technology networks, resulting in more local specific 
knowledge acquisition. Consequently, US R&D centers can increase their value and give the 
headquarters more incentives to collaborate with them. Given these two possibilities, the 
following hypotheses are proposed. Figure 1 summarizes all the hypotheses. 
 
Hypothesis 3a. The more a firm has the independence capability to acquire local 
technologies autonomously, the lower the combinative capability of the firm is. 
 
Hypothesis 3b. The more a firm has the independence capability to acquire local 
technologies autonomously, the higher the combinative capability of the firm is. 
 
------------------------------------- 
Insert Figure 1 about here. 
------------------------------------- 
 
METHODS 
Research setting 
These hypotheses are tested in the context of the R&D activities of East Asian (Japanese 
   
- 10 - 
 
 
and Korean) and European (German, Swiss, Dutch, Swedish, and Finnish) MNCs that carry 
out research activities of their corporate R&D centers in the US as well as in their home 
countries. All the countries where the MNCs are headquartered are members of the OECD 
and invest a high percentage of their GDP in R&D. These countries in Europe and Asia share 
national borders and/or similar backgrounds culturally and historically. The unit of analysis is 
a firm. I focus on the electronics/engineering, automobile, chemical and pharmaceutical 
industries. Firms in these industries also have relatively high R&D intensity (R&D 
expenditure/sales). The propensity to patent differs across industries, and some firms are less 
interested in filing patents, which makes it difficult to compare the success in developing 
inventions of firms by means of patent data (von Hippel, 1994). Nevertheless, large MNCs, 
particularly those in these industries I study, file patents vigorously enough for researchers to 
use patent data to analyze their R&D activities (Patel et al., 1997).  
 
Sample 
After choosing the home countries and industries of firms to be sampled, I identified the 
population of the potential sample firms to be studied from the lists that ranked firms of each 
country or by sector worldwide (e.g., “OECD Outlooks,” “Shushoku-shiki.hou WEB,” “Die 
Zeit,” ”World Investment Report 2002”). Then I chose the firms which had research activities 
of corporate R&D centers in the US and which were accessible to us because I had prior 
contacts or potential contacts with through mediating people or organizations such as 
industrial organizations and research institutes. These personal contacts and introduction by 
local networks were very important because of the sensitivity of the subject of R&D activities. 
Then I made exploratory semi-structured interviews. Finally 47 observations of 45 firms
1
, 
which I interviewed at least once, are included in the sample as listed in Table 1. 
 
------------------------------------ 
Insert Table 1 about here. 
------------------------------------ 
 
Data 
In this paper I use four sets of data: 1) public company data regarding sales and R&D, 2) 
                                                 
1
 Bayer and Merck have chemical and pharmaceutical business units, each of which has its own corporate 
R&D centers and decision making units at the top level. Therefore these two business units of each firm are 
treated as separate observations. 
   
- 11 - 
 
 
patents, 3) interviews and 4) responses to my questionnaires. The data for the statistical 
analysis consist of sales by region and information on the patent inventors of each firm, 
whereas the last two are used to interpret the statistical results. First, the public company data 
on sales and R&D expenditure were gathered from their special reports to the national 
authorities of the stock markets or US authorities as well as from their annual reports. When 
these data were not included in published reports, enquiries were made to each company 
directly.  
Second, in this study, the patent data are used as the main source of information to track 
technological innovations in the dispersed R&D locations of the Japanese and European 
MNCs. I analyzed a total of 613,583 patents that were granted to the sample firms (including 
their consolidated subsidiaries) in the study. These were the patents filed first between 1995 
and 1999, either with the US Patent and Trademark Office (USPTO), the European Patent 
Office (EPO), the World Intellectual Property Organization (WIPO) or the national patent 
offices of the countries where the firms’ headquarters are located. Because MNCs often 
subsequently file patents for the same invention in several countries, I used only the first-filed 
patents in order to avoid double or triple counting. These data were selected by the EPO 
which has all the patent data filed in the patent offices above. The numbers of patents granted 
for the same number of inventions differ in the different patent systems in each region and 
country. Therefore, I scaled down the number of Japanese and Korean patents by a factor of 
4.9 to re-evaluate the volume of inventions.
2
  
I chose the patents whose priority date (i.e., the date a patent application was filed in any 
country that has signed the Paris Convention) was between 1995 and 1999. These dates were 
chosen primarily because of the comparability of patent data as follows. The first reason is the 
time lag between inventions and market performance. The average time lag varies across 
sector. However, it takes at least three to four years according to the interviewees. Since the 
sales were measured as of 2002, I decided to include patents first filed until the end of 1999. 
Second, firms’ patent strategy had evolved since the early 1990s. German firms, in particular, 
                                                 
2
 To deal with the problem of varying numbers of patents per invention, Eaton and Kortum (1999) used a 
factor of 4.9 to scale down domestic patents in Japan based on the analysis of Okada (1992). Using the data on 
the number of claims of inventions, Okada finds that Japanese patents granted to foreigners contain on average 
4.9 times as many inventive claims as those granted to Japanese inventors, and others all have a similar average 
number of claims per patent. In addition, according to the study of EPO, the factor to scale down Japanese 
patents should be between 3 and 5. In addition, the Korean patent system is very similar to the Japanese one due 
to their historical assimilation of every Japanese policy, which was confirmed by experts on the patent issue. 
Hence it is assumed the Korean patents have a similar tendency to those of the Japanese. Therefore I tested the 
factors of 3 and 4.9, and the principal results were same.    
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increased their patent filings despite the stable R&D expenditure during the same period. 
Third, Japanese firms became more intensive in their internationalization in the 1990s, while 
some companies, particularly in small countries, started to internationalize their R&D 
activities much earlier (Kuemmerle, 1999). For the last two reasons, it was necessary to limit 
the data filed after 1995.  
The reason for choosing 1999 was that, before November 2000, US law did not allow 
publication until patents were granted. Because it takes at least two to three years for the 
patents to be granted, some of the applications filed after 2000 did not appear in the US patent 
data (Testing with the patent data of several firms showed a sharp decline of the numbers of 
patents granted that were filed after 2000.). Thus I chose priority dates up to the end of 1999 
to make comparison of the US patent data with those of the other places where publications 
are made 18 months after the priority dates so that, as of the end of 2003, it was possible to 
obtain the addresses of inventors with priority dates up to the middle of 2002 (The patent data 
were provided by the EPO in February 2004).  
Third, as regards interview information, I conducted extensive semi-structured 
interviews with over 250 managers in the Japanese and European firms in the three regions, 
Japan, Europe and the US, from 2001 to 2005. The primary objective of the interviews was to 
explore and understand the facts because international R&D activities at a firm level with 
respect to organization and management are still understudied. Fourth, in parallel with the 
exploratory interviews, I invited the selected firms to participate in my 50-page long 
questionnaire survey. About 40 firms expressed an initial interest and were visited at least 
once to conduct structured interviews and the completion of questionnaires at their 
headquarters or main corporate R&D centers from 2003 to 2004. From the summer of 2003 to 
the summer of 2004, the questionnaire survey was conducted usually during face-to-face 
interviews with senior managers at the corporate R&D centers in the home country who were 
usually to report to the chief technology officer (CTO) or the second to the CTO. Though 
these primary data of the interviews and survey are useful sources of information, I restrict my 
attention mainly to analyses of the patent and sales data in this paper and use the questionnaire 
and interview data only as a reference to interpret the statistical results for this study.  
 
Statistical methods 
To test the hypotheses, I conducted bivariate and multivariate analyses. The multivariate 
regressions included four control variables, sector, region, R&D expenditure and R&D 
intensity, for the reasons explained in the following section on the construction of measures. 
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For the multivariate analyses to test hypothesis 1, I used ordinary least squares (OLS). To test 
hypotheses 2a, 2b, 3a, and 3b, I employed path analysis
3
 and also used OLS to test each effect 
of one variable on the other. Since my model for hypotheses 2a, 2b, 3a, and 3b is essentially a 
recursive simultaneous equation model (i.e., no variable affects and depends at the same time 
on another variable), path analyses provide better estimates for hypotheses 2a, 2b, 3a and 3b 
because they take into account potential correlations among disturbances across equations and 
give insights into the causal ordering of variables in a system of relationships.  
 
Construction of measures 
“Absorptive capacity” is regarded as a complex construct and difficult to measure and 
operationalize (Lane et al., 2002). Lane, Koka and Pathak (2002) argue that the two 
dimensions (the ability to assimilate and to commercially apply external knowledge) are even 
more difficult to operationalize than the two other dimensions (the ability to search and 
evaluate) because the former two dimensions are fundamentally process-oriented and thus not 
readily measurable by publicly available archival data. This implies the last three stages - 
acquisition, combination and utilization - are especially difficult to measure and 
operationalize. However, this study aims to address this problem by relying on patent and 
sales data of firms as described in the following.  
 
Acquisition capability. Acquisition capability (ACUS), defined as the capability of a 
firm to acquire technological knowledge in the US through their US R&D centers, is 
measured by the proportion of patents which have at least one US inventor to all the patents of 
a firm first filed at USPTO, EPO, WIPO, or the patent office in the home country. Figure 2 
illustrates the measure of this construct by the sum of the shares of b, d, e and g (the letter in 
each area in the diagram indicates the share of the patents in the area of all the patents of a 
firm) of the total patents granted to a firm by the above patent offices. Firms with higher 
acquisition capability are regarded as having a greater capability to make use of US people 
who embody US knowledge and contribute to new inventions.
4
 
                                                 
3
 I follow the convention of calling this path analysis. Path analysis is referred to as “structural equation 
model” when the variables in the model are latent and measured with multiple observed variables using factor 
analysis. In my model there is only one measured variable per concept. (see Barton, J. & Mercer, M. 2005. To 
blame or not to blame: Analysts' reactions to external explanations for poor financial performance. Journal of 
Accounting & Economics, 39: 509-533.)  
4
 A particular drawback of this measure may be that home country inventors who moved to the US are 
counted as US inventors and vise versa. However, these people have absorbed the US technological knowledge 
while they work in the US, and, therefore, the patents contributed by them are regarded as reflecting US 
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----------------------------------- 
Insert Figure 2 about here. 
----------------------------------- 
 
This measure has often been used by other studies using patent data to evaluate the level 
of technology absorption of MNCs abroad. However, these studies usually rely on patents 
granted by a single patent office such as USPTO (e.g., Cantwell et al., 2000) or EPO (e.g., 
Bas & Sierra, 2002), though where to file patents varies depending on the nationality, industry 
and strategy of a firm. In addition, they do not distinguish patents contributed solely by host 
country inventors and patents jointly contributed by home and host country inventors. To 
address these weaknesses, this study uses patents filed in all the places where Japanese and 
European MNCs are most likely to file their patents. Moreover, it pays attention to the 
differences in the patterns of inventors’ addresses as follows. To the best of my knowledge, 
this is the first attempt to use these dimensions of patent data. 
  
Combinative capability. Combinative capability (USCC) is measured by the proportion 
of all the patents granted to a firm that have both US and home country (and other) inventors 
(d and g in Figure 2). The proportion of patents co-invented by home and host country people 
reflects the level of knowledge integration and transfer across countries. Integration of 
knowledge involves a tacit dimension and is possible only through intensive human contacts 
enabled by activities such as co-inventions.  
 
Independence capability. Independence capability (USOL) is measured by the 
proportion of all the patents granted to a firm that have only US inventors (b in Figure 2). It 
reflects the degree of autonomy of a US subsidiary to explore local knowledge to create 
subsidiary specific value and to make new inventions in the US independently of its 
headquarters.  
 
Utilization capability. Utilization capability (USM), an ability to commercialize 
acquired knowledge for the US market, is measured by the performance of a firm in the US 
market, specifically by the share of the total sales of a firm that come from the US market. A 
                                                                                                                                                         
knowledge. In addition, according to the interviews with managers of MNCs, the proportion of expatriates in the 
US is relatively small (around 5%). 
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problem with this measure is that it fails to take into account cases where US technologies are 
used to contribute mostly to the home markets of firms. However, the interviews with firms 
revealed that the primary target of US R&D centers is usually the US, both home and US or 
global market including the US because they aim to develop products of which the US is the 
lead market.  
 
Control variables. Four control variables are included: (1) R&D expenditure (RDE) 
and (2) R&D intensity (RDI), (3) region and (4) industry. The reasons are as follows. 
Researchers have recognized differences in AC by country and industry (Cantwell et al., 
2000; Patel et al., 1997). Therefore this study also uses the control variables of region 
(Japan/Korea vs. Europe) and industry (electronics/automobiles vs. 
pharmaceuticals/chemicals). As for R&D expenditure, firms need internal R&D capability to 
assimilate external R&D knowledge. Prior research finds firms’ R&D investment increases 
acquisition of external technologies (Lim, 2004; Rosenberg, 1990; Veugelers, 1997). Thus 
firms’ total R&D expenditure is expected to influence absorption of US knowledge positively.  
In addition, the R&D intensity (RDI) of a firm is included to capture the differences in 
firms’ commitment to developing their knowledge basis. Cohen and Levinthal (1990) find the 
positive association between “absorptive capacity” and R&D intensity, whereas applied 
economists identify three classes of industry-level determinants of R&D intensity, demand, 
appropriability and technological opportunity conditions, which influence “absorptive 
capacity” (Cohen & Levinthal, 1989). Thus, including this control measure enables us to 
better assess the interrelationships between various capabilities being independent of such 
influence. 
The factor analysis, including the variables of the four capabilities as well as R&D 
expenditure, R&D intensity, total annual sales, total employees and share of R&D people of 
corporate R&D centers in the US, tells us that R&D expenditure, total annual sales and total 
employees, belong to one of the two components, whereas R&D intensity is in another, and 
all the other variables are in the other component (Table 2). R&D expenditure is strongly 
related to other measures of firm size (total annual sales and total employees), whereas R&D 
intensity is not. Therefore, I employed R&D expenditure to control the firm size in addition to 
the other reason given above for using R&D expenditure as a control variable.
5
  
 
                                                 
5
 I also used the total sales of a firm to control the size of a firm instead of R&D expenditure, but the 
results were almost same. 
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--------------------------------- 
Insert Table 2 about here. 
--------------------------------- 
 
RESULTS OF STATISTICAL ANALYSES 
Descriptive statistics 
Table 3 shows the means of key variables by region and industry. On average, compared 
in the same industries, European MNCs have higher annual turnover, utilization capability, 
R&D expenditure and R&D intensity than their Japanese/Korean counterparts. Their share of 
R&D staff in the US is also higher. US market share and R&D intensity are slightly higher for 
pharmaceutical and chemical industries in both regions, although turnover and R&D 
expenditure are higher for electronics and automobile industries. The Japanese/Korean 
electronics and automobile firms have a higher percentage of expatriates in their US R&D 
centers on average. In terms of the variables based on patent data, the acquisition capability, 
combination capability and independence capability of the European firms are much higher 
than those of the Japanese/Korean firms. 
 
----------------------------------- 
Insert Table 3 about here. 
----------------------------------- 
 
Results of OLS and path analysis 
The bivariate correlations are shown in Table 4 and Figure 3. The results of the 
multivariate regressions with the control variables, region, industry, R&D expenditure and 
R&D intensity, are shown in Table 5, whereas Figures 4 and 5 summarize the results of 
ordinary least squares (OLS) and path analysis respectively.
6
 
 
------------------------------------------------------------------- 
Insert Tables 4 and 5 and Figure 3, 4, and 5 about here. 
------------------------------------------------------------------- 
 
                                                 
6
 White’s test for heteroskedasticity was carried out for each regression. No evidence of a problem was 
detected at the 0.05 level of significance.   
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The first hypothesis predicted a positive impact of acquisition capability on utilization 
capability measured by the performance of the US market share of the total sales. The result 
of the test using the bivariate analyses is consistent with my expectation. However, the result 
becomes insignificant in OLS. This suggests that a firm which acquires more US 
technological knowledge does not necessarily have a higher share of US sales of all its sales. 
Firms vary in making use of US knowledge and turning it into profits. 
Hypotheses 2a and 2b predicted a positive effect of combination and independence 
capabilities on utilization capability. To test these, both OLS and path analysis were used 
because of the predicted relationships between combinative and independence capabilities in 
Hypotheses 3a and 3b. The result of the test using the bivariate analyses support these 
hypotheses, but those of the OLS and path analyses show only Hypothesis 2a has a 
statistically significant result: There is a significant positive effect of combinative capability 
on utilization capability (the unstandardized coefficient = 1.468 and p<0.1 in OLS; and the 
unstandardized coefficient = 1.521 and p<0.1 in path analysis). In path analysis, a 
multicollinearity issue needs to be considered, and therefore variance inflation factors (VIFs), 
which measure the inflation in parameter estimates due to collinearities among independent 
variables, were calculated. As Table 6 shows, all the VIFs are much smaller than 10, which is 
the value commonly used to indicate the presence of severe multicollinearity. 
 
--------------------------------- 
Insert Table 6 about here. 
--------------------------------- 
 
It is notable that combination capability, but not acquisition capability or independence 
capability, has a significant positive effect on utilization capability.
7
 The results suggest that 
to achieve high turnover in the US, acquiring US knowledge is not enough, but combining US 
knowledge with home knowledge is the key. As mentioned later in the section, R&D 
expenditure is significantly correlated with utilization capability in the regression analysis 
controlled by region, sector and R&D intensity. This implies MNCs that have higher 
utilization capability have a strong R&D capacity at home base which constitutes the 
competitive advantage of a firm. At the same time, these firms must have a capability to 
                                                 
7
 Since there may be diminishing returns of acquisition capability (ACUS) and independence capability 
(USOL) to the US sales, Log(ACUS) and Log(USOL) were also used to substitute ACUS and USOL in the 
hypotheses 1 and 2b respectively, but the results were almost same while the adjusted-R squares improved only 
by less than 0.01.  
   
- 18 - 
 
 
combine it with US knowledge, which complementarily strengthens their R&D capacity at 
home. The statistical results show that the two conditions need to be met to achieve high 
utilization capability.  
To the best of my knowledge, this is the first time it has been possible to demonstrate 
empirically that combinative capability of cross-border technological inventions constitutes an 
important part of core competence resulting in actual economic performance in the local 
market. This supports the argument that combinative capability is the key to innovation and 
sustaining the competence of firms. It could also imply that there may be certain 
organizational characteristics which underlie and enable both combinative and utilization 
capabilities at the same time.  
With regard to the relationship between control and autonomy, Hypotheses 3b is 
supported by the bivariate analyses, but not by the path and OLS analyses at the 0.1 level, 
although both statistical analyses, bivariate and multivariate, show a positive effect of 
independence capability on combinative capability. The results of the bivariate correlations 
show that, when the number of patents of a firm to which only US people have contributed is 
higher, their combinative capability is also higher. This may imply that US R&D centers 
which enjoy more freedom may have more attractive knowledge to combine with home 
knowledge because the subsidiaries may be more embedded in local R&D networks and 
absorb technological knowledge from them (Andersson et al., 2002).  
The result, however, becomes insignificant in the multivariate regression analyses 
including the four control variables: region, industry, R&D expenditure and R&D intensity. It 
shows that there is a positive, but not significant, effect of independence capability on 
combinative capability. This result may suggest trade-offs as well as a positive interrelation, 
one increasing the other, between the two capabilities. Because there are competing needs 
between the two capabilities underlying control and autonomy, the two capabilities influence 
each other in opposite directions, making the positive effect of independence capability on 
combinative capability insignificant. These may imply that it is desirable and possible to 
increase both capabilities while it is difficult to strike a right balance between the two 
capabilities.  
 
Results of control variables 
R&D intensity has a significant positive impact on acquisition capability at the 0.1 level 
when controlled by region, industry and R&D expenditure. This may suggest that firms 
involved in new rapidly changing technology fields (which require a higher R&D intensity) 
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need to absorb more technological knowledge from the US. The effect of R&D intensity on 
independence capability is also significantly positive at the 0.05 level, but not on combinative 
capability. The findings may suggest that firms involved in rapidly changing technology fields 
need to allow more autonomy of R&D subsidiaries to explore new possibilities in the US.
8
  
R&D expenditure has a significant positive effect on utilization capability at the 0.05 
level, but does not have a significant impact on acquisition, combinative or independence 
capability. It is argued that the assimilation of outside technology and the cultivation of in-
house technological capabilities are twin processes for high technology based firms 
(Cusumano et al., 1994). Veugelers (1997) found the positive relationship between R&D 
investment and the “absorptive capacity” of a firm, pointing out the importance of internal 
R&D to acquire external R&D knowledge. The result of this study, however, indicates the 
importance of total volume of R&D expenditure to exploit the US market, but not to acquire 
technologies in the US. The reason that the volume of R&D expenditure does not have an 
impact on acquisition capability may be that firms with a strong R&D competence at home do 
not need to acquire US knowledge and therefore have not developed this capability. These 
results suggest there is a need for a closer examination of the current arguments concerning 
the relationship between the in-house R&D and AC of MNCs. 
 
TAXONOMIES BY FOUR CAPABILITIES COMPOSING AC 
Meanings of two taxonomies 
In order to advance our understanding of the relationships between the four capabilities 
examined in the statistical analyses, two types of taxonomies are created based on two pairs of 
two constructs: (1) acquisition capability and utilization capability and (2) combinative 
capability and independence capability. The categorizations of existing studies in international 
R&D management at a firm level usually rely on subjective criteria of researchers such as 
interviews and questionnaires (Gerybadze & Reger, 1999; von Zedtwitz & Gassmann, 2002). 
However, in this study, I use more objective criteria, patents and sales, to measure the four 
capabilities of AC to help elucidate the organizational and managerial characteristics of firms 
in each category. To explore the characteristics of firms in each category, I rely on the 
information mainly from the interviewees of MNCs and other sources. Because of the 
                                                 
8
 In addition, R&D intensity has a significant positive effect on utilization capability at 
the 0.1 level, but it has a significant negative correlation with the share of the sales in the 
home country (HOM) and no significant correlations with the share of the sales in the home 
region (HRM). This implies that the US market is very important especially for firms whose 
R&D intensity is high. 
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confidentiality, it is not possible to describe the details of each firm in the taxonomies. 
Therefore, the main purpose of this section is to explain the common features of the firms 
included in the same group in the taxonomies and to help understand the meanings of the four 
capabilities at a firm level. 
 
Taxonomy of firms by acquisition and utilization capabilities 
Tables 7 and 8 show the position of each firm with respect to its acquisition and 
utilization capabilities. The firms are divided into electronics & automobiles (Table 7) and 
pharmaceuticals & chemicals (Table 8) to control industry differences and then placed into 
each category depending on whether their acquisition and utilization capabilities are higher or 
lower than the median.  
 
--------------------------------------------- 
Insert Tables 7 and 8 about here. 
--------------------------------------------- 
 
National focus R&D. The firms in the “national focus” group in Tables 7 and 8 have 
acquisition capability and utilization capability that is below the median. Japanese chemical 
and electronics firms are mostly of this type. According to the interviewees, the purpose of 
their R&D activities in the US is primarily to support production, technology monitoring and 
scanning, often with “listening posts,” and/or to absorb a small amount of specific 
technologies mainly for their home market and to a lesser extent for adaptation to the US 
market. The firms in this category may have home markets profitable enough to afford the 
costs of their R&D. In addition, their technologies are mature and do not require the firms to 
acquire much US knowledge.  
These firms, therefore, tend to have little incentive to internationalize their R&D. The 
low US market share may indicate that the costs of increasing product development capability 
and marketing/sales capability for the US market would exceed the potential profits in the US 
market. Therefore their strategy is to focus on their home market and home technologies 
while the cost of changing the organization to increase acquisition capability and utilization 
capability is higher than potential benefits.  
 
Technology-oriented R&D. The firms in the “technology-oriented” group have higher 
acquisition capability and lower utilization capability than the median. There are both 
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Japanese and European firms in this category. The R&D operations of these firms are 
technology-driven rather than market-driven. Their exploitation of US technologies in the US 
market is not as vigorous as the firms with more than average utilization capability. It is 
possible that they are investing heavily in improving product development and 
marketing/sales to adjust to the US market although they have not yet succeeded in reaping 
the economic benefits from acquiring US technologies. Thus they may be in the process of 
transforming their strategy and organization to those of the firms in the “integrated” group. 
Alternatively, they may have moved from the “integrated” group recently as their US sales 
declined, but continue to maintain the previous level of R&D activities in the US. 
 
Market-oriented R&D. The firms in the “market-oriented” group are characterized by 
below median acquisition capability, but above median utilization capability. These firms tend 
to have very strong technological capabilities, which are centered on their home countries and 
exploited in the US market. They have not seen an urgent need to acquire US knowledge yet. 
Therefore, their R&D activities in the US tend to be more market-driven, i.e., for adaptation to 
the local market, than “technology-oriented” firms. “Market-oriented” firms have relatively 
small capabilities for acquiring US knowledge, but may be good at adapting to the US market 
by integrating US technologies with those at home for new product development. They may 
well possess the marketing/sales competence needed to sell products in the US. Having 
attained high sales performance in the US without relying much on US technological 
knowledge, the firms in this group may have little incentive to acquire more technologies 
from the US.  
Table 8 shows that four automobile companies out of the six in the sample belong to this 
type. DaimlerChrysler, formed by the merger of a German and an American company in 1998, 
and Honda are the only exceptions. This suggests that the Japanese and German automobile 
firms still rely heavily on and exploit home based R&D in overseas markets. The interviews 
with the managers of the automotive industry revealed that their firms needed to acquire only 
a narrow range of specific knowledge in the US, such as Internet technologies, 
complementary to their core technologies at home. As regards the regional difference, 
comparing within the same industries (Tables 8 and 9), the firms in this category are mostly 
Japanese firms with the exception of BMW and Volkswagen. This may indicate that Japanese 
firms rely more on home R&D than their European counterparts to increase their sales in the 
US market. 
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Integrated R&D. The last “integrated” group includes firms that have both higher 
acquisition capability and higher utilization capability than the medians. This means that the 
firms in this category are both technology and market oriented. They possess substantial 
technological competence in their US R&D centers and, at the same time, can utilize the 
acquired US knowledge through their product development and marketing/sales. This 
suggests that the firms in the “integrated” group have the organization to leverage and exploit 
both home and US resources more successfully than the firms in the other types.  
All the firms from small countries, except for Ericsson, are in this group. In addition, 
most of them in Table 9 are in pharmaceuticals. This may mean that firms in the 
pharmaceutical industry need to acquire more US R&D knowledge to be successful in the US 
market than those in the chemical industry because of more radical technological change, such 
as the mergence of biotechnologies, in the US. Thus I may speculate that, in the 
pharmaceutical industry, the home technological advantage is smaller for firms headquartered 
in Japan and Europe than for firms in the US. 
 
Questions derived from the relationships between acquisition and utilization 
capabilities. As Tables 8 and 9 demonstrate, there are technology-oriented firms with higher 
acquisition capability, but lower utilization capability, and there are also market-oriented 
firms with lower acquisition capability, but higher utilization capability. This corresponds to 
the statistical results despite the conventional expectation: acquisition capability and 
utilization capability are not associated with each other significantly. Why do some firms with 
higher acquisition capability not achieve higher utilization capability? Why can some firms 
with lower acquisition capability reap higher economic return in the US market? Are there 
any other reasons besides those explained above? To shed light on this question, I look into 
the meanings of combinative and independence capabilities at a firm level and explore the 
implications of the relationships between the two capabilities in the process of the absorption 
of knowledge from abroad.  
 
Taxonomy of firms by combinative and independence capabilities 
In international management, the autonomy of subsidiaries and control by the 
headquarters are seen as two competing elements. On the one hand, as regards combinative 
capability, firms leverage and create additional value by combining home and US 
technologies while such combination may require tighter control by the headquarters. On the 
other hand, as for independence capability, autonomy may allow subsidiaries to be more 
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embedded in the local science and technology network and to facilitate assimilation of local 
specific knowledge. The previous section finds that combinative capability has a significant 
positive effect on utilization capability, the share of the US market of each firm. The effect of 
independence capability on combinative capability is positive, but not significant. It is, 
therefore, critical to investigate the relationship between combinative and independence 
capabilities more carefully for each firm in order to understand the characteristics and 
relationships of these two conflicting capabilities. As in the previous sections, the position of 
each firm is shown in Tables 9 and 10, depending on whether the levels of combinative and 
independence capabilities are above or below the median.  
 
------------------------------------------------ 
Insert Tables 9 and 10 about here. 
------------------------------------------------ 
 
Paternalistic partnership. The firms in the “paternalistic partnership” group have 
lower combinative and independence capabilities than the medians. Most of the firms in this 
category are Japanese. The firms of this type tend to rely on researchers/engineers in their 
home countries rather than on US researchers/engineers. This implies that the innovation level 
of these US centers is relatively low and therefore unattractive to the technological centers in 
the home country. Their main R&D activity in the US is mostly monitoring, scanning or 
production support. There may be only a small amount of specific US knowledge that they 
need for their home markets. The firms in this category have not yet found enough benefits to 
increase their R&D activities in the US and do not regard them as an important source of their 
technologies.  
 
Intensive partnership. The firms in the “intensive partnership” group exhibit higher 
combinative capability and lower independence capability. The technological knowledge in 
the US is attractive and is necessary for these firms to combine with that at home. Intensive 
collaborations between US and home R&D staff are required to share technological 
knowledge. This may imply that their home and US R&D centers are heavily engaged in the 
same or very closely related fields of technologies and/or co-work for product development 
with each other. The firms in this group may have more standardized R&D processes to 
enable such collaboration across national borders more effectively. Some firms in this 
category may not need to rely on a wide range of US technologies and, therefore, do not allow 
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their US subsidiaries much room to explore their own areas of research independently. 
 
Divided partnership. The firms in the category of “divided partnership” are 
characterized by lower combinative capability and higher independence capability; their US 
centers are more independent from the headquarters than the average. This suggests they have 
a clearer division of labor between home R&D and US R&D. The role of US R&D centers 
may be mostly one of local adaptation, or the firms may be good at separating development, 
for example, by dividing into modules to reduce intensive interactions between home and the 
US. Another reason for the division of labor may be that US R&D centers were obtained as a 
result of acquisitions of local firms and deal with technologies unrelated to the R&D at home. 
It could also mean that US subsidiaries have become large and autonomous enough to be self-
contained in the US. As a result, they may have gained a bargaining power, and the level of 
control of the headquarters and sharing knowledge may have declined. 
 
Independent-mutual partnership. The firms in the category of “independent-mutual 
partnership” have higher combinative capability and higher independence capability. 
Divided by sector, all the firms from the smaller countries are in this group. The firms in this 
group are able to integrate home and US knowledge more often than the average, and at the 
same time have independent technological capability at home and in the US. This may 
suggest that, while their US R&D centers have broader R&D competence than the average, 
the R&D centers in the US and at home depend on each other to introduce new products. 
The extent of independence of US R&D centers in this category may mean that these US 
centers used to be part of US firms acquired by the Japanese or European firms, which 
achieved integration between the US R&D and home R&D.  
 
Comparison of the two taxonomies. Interestingly, the comparison of the two taxonomies 
reveals that all the electronics/engineering and automobile firms in the “independent-mutual 
partnership” group (higher combinative and higher independence capabilities) excluding 
Fujitsu, NEC and Ericsson belong to the “integrated” group (higher acquisition and higher 
utilization capabilities). In addition, all the pharmaceutical and chemical firms in the 
“independent-mutual partnership” group are identical as those in the “integrated” group 
except for Schering. This suggests accomplishing both higher combinative and higher 
independence capabilities may be an important prerequisite for achieving higher acquisition 
and higher utilization capabilities at the same time, though it may not be a sufficient condition.   
   
- 25 - 
 
 
 
CONCLUSIONS AND LIMITATIONS 
 
A number of researchers have used the “absorptive capacity” construct, but its the 
operationalization has been a problem (Zahra et al., 2002). In addition, only a few studies 
have expanded and elaborated on the multiple dimensions of the capacity. Above all, the AC 
of MNCs in R&D management has been an under-studied issue. The results of this paper 
contribute to the understanding of the multiple dimensions of the AC of MNCs in the context 
of cross-border technology absorption.  
First, I identified four capabilities (dimensions) that together constitute AC and 
investigated how these four types of capabilities in AC are interrelated. The statistical 
analyses revealed that there is no significant effect of acquisition capability on utilization 
capability. The result also shows no significant association between independence and 
utilization capabilities. This implies the autonomy of the US R&D centers does not 
necessarily increase US market sales by itself. Instead, I found the significant positive 
association of combinative capability with utilization capability, suggesting the importance of 
core technological knowledge at home as well as the critical role of intensive collaboration to 
integrate and utilize both home and US knowledge in enhancing their economic performance 
in the US market. It is vital for firms to possess competitive technological advantage at home, 
which enables them to exploit the US markets especially when combined with US 
technologies, whereas combinative capability serves as glue to combine the core knowledge at 
home with the acquired US knowledge. To the best of my knowledge, this is the first time it 
has been possible to demonstrate empirically that combinative capability of cross-border 
technological inventions contributes to the actual sales performance in the host market.  
Second, the taxonomies discussed in this paper allowed us to seek how the different 
types of capabilities of AC may be interrelated focusing on individual firms, together with the 
statistical results and the qualitative information. As shown in Tables 8 and 9, there are firms 
that have higher acquisition capability, but lower utilization capability. This coincides with 
the statistical results of the positive, but insignificant effect of acquisition capability on 
utilization capability. Why are firms which acquire US technologies not necessarily able to 
exploit them in the US market? The comparison of the two taxonomies shows that firms with 
both higher combinative capability and higher independence capability are very likely to have 
both higher acquisition capability and utilization capability. The findings suggest that the key 
to achieving a high level of utilization as well as a high level of acquisition of US 
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technologies may be the balance between the autonomy and control of foreign subsidiaries.  
Given these results of the statistical analyses and taxonomies, I discuss the following. 
For firms to exploit US technological knowledge successfully, volume of acquisition is not 
sufficient, though it is a necessary precondition. In order to absorb US technological 
knowledge effectively, firms need to attain both higher combination and higher independence 
simultaneously. On the one hand, independence capability is important because firms must 
allow their US R&D centers to develop their own competence in a way that is broadly 
independent from the headquarters and to explore and acquire US specific knowledge. On the 
other hand, it is critical that home and US R&D centers cooperate with each other and 
combine their R&D competences across borders to exploit the US market. It is very likely that 
there are mediating effects of combinative and independence capabilities on the relationships 
between acquisition and utilization capabilities.  
Higher independence capability is likely to increase the technological attractiveness of 
US subsidiaries and motivation of parent firms to combine it with home technologies. The 
statistical result reveals that combinative and independence capabilities are positively 
interrelated, though not significantly. In addition, the taxonomy presents most of the firms are 
located in the “independent-mutual” or “paternalistic” group. Importantly, however, the two 
capabilities are usually considered as being incompatible from a managerial perspective 
because autonomy and control are competing elements. The relationship between autonomy 
and control may correspond to the relationship between exploration and exploitation 
suggested by March (1991). Autonomy can encourage the exploration of US knowledge 
whereas control can facilitate the exploitation of US knowledge by combing it with 
complementary knowledge at home as illustrated by Figure 6. March (1991) argues in 
organizational learning, there is a tension between exploration and exploitation, and that the 
excess of one of the two is destructive in the long run. Similarly, the excess of either 
autonomy or control can be destructive. Thus managers may face a dilemma in coping with 
the two conflicting needs, autonomy and control, to achieve higher AC by balancing 
independence and combinative capabilities simultaneously, as is the case for coping with 
exploration and exploitation.  
 
---------------------------------- 
Insert Figure 6 about here. 
---------------------------------- 
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The analysis of the relationships between acquisition, independence, combination and 
utilization capabilities suggests what may be called “positive loop effects.” In the loop, to 
begin with, firms give more autonomy to subsidiaries to improve their local specific 
technological knowledge, i.e., enhancing independence capability. Then they start reaping the 
investment by combining subsidiaries’ knowledge with that at home for cross-border 
innovations, i.e., increasing combinative capability. This provides a basis for firms to exploit 
and commercialize US knowledge and to make actual profits. This process, if successful, will 
encourage firms to invest more in acquiring US technologies and further improve their sales. 
In the loop, combinative capability is the key to improving utilization capability, while 
independence capability is the key to enhancing acquisition capability. Both combinative and 
independence capabilities are critical for the whole process, and the balance between the two 
needs to be created for sustainable knowledge absorption. 
There are several limitations recognized in the statistical analyses. First, the relatively 
small sample lowers the power to investigate inter-correlations between some of the variables 
and the reverse effects, i.e., the effects of utilization capability on acquisition, combinative 
and independence capabilities. Second, the AC measured was absorption of technological 
knowledge through people’s inventions, which are realized as patents. In addition to the usual 
disadvantages of using patent data, this limits the analysis of a wider range of AC by other 
means, such as learning from scientific papers and patents, and reverse-engineering. Third, for 
more accurate analyses, it may be necessary to analyze the data controlled by technology and 
country although it is controlled by industry and region in this study. It will, however, require 
a much larger patent data set and sample size, which we did not have for this study since the 
number of firms that can afford to establish corporate R&D centers in the US are very much 
limited. Finally, the use of patent data granted in different patent offices could be a source of 
bias. To mediate this problem, two factors, 3 and 4.9, were used to scale down the number of 
Japanese and Korean patents, and the principal results were basically same for both factors. 
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TABLE 1  
Companies in sample 
 
Country Electronics/Engineering Automotive Pharmaceuticals Chemicals Total 
Japan Canon, Epson, Fujitsu, Fuji-
Xerox, Hitachi,  
Mitsubishi Electric, NEC, NTT 
DoCoMo, OKI, OMRON, 
Matsushita Electric Industrial, 
Sharp, Sony, Sumitomo Electric 
Industries, Toshiba (15) 
Honda, Nissan, 
Toyota (3) 
Eisai, Fujisawa, 
Takeda, 
Yamanouchi (4) 
Hitachi 
Chemicals, 
Mitsubishi 
Chemicals, 
Sumitomo 
Chemicals 
(3) 
25 
Korea Samsung, LG (2)    2 
Germany Bosch, Infineon, Siemens (3) BMW, 
DaimlerChrysler, 
Volkswagen  (3) 
Bayer, Boehringer-
ingelheim, Merck, 
Schering (4) 
Bayer, 
BASF, 
Degussa, 
Merck  (4) 
14 
Switzerland ABB (1)  Roche, Novartis (2)  3 
Netherlands Philips (1)    1 
Finland Nokia (1)    1 
Sweden Ericsson (1)    1 
Total 24 6 10 7 47 
Note: Bayer and Merck are divided into chemical and pharmaceutical divisions. 
 
TABLE 2 
Factor analysis (Rotated component matrix) 
 component 
 1 2 
Total turnover 
Total employees 
RDE 
RDI  
ACUS 
USCC 
USOL 
USM 
USR 
-.166 
-.136 
.109 
.724 
.843 
.722 
.855 
.652 
.658 
.950 
.922 
.970 
-.269 
-.086 
-.070 
-.119 
.305 
.001 
Note:  Turnover, share of sales by region and country, employees, RDE and RDI are based on the consolidated data as of 2002. 
USR is a share of R&D personnel in US corporate R&D centers of a firm’s corporate R&D centers in the world. 
Sources:  USR and USE are from individual firms, patent data are from the EPO, and the rest are from company reports. 
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TABLE 3 
Means by region and industry 
 
 Industry  
(Number of sample firms) 
Turnover 
(US$ million) 
Sales in US 
(US$ million) 
Employees RDE (R&D 
expenditure) 
(US$ million) 
RDI 
(R&D 
intensity) 
East Asia Electronics & Automobile (20) 37827.3 9389.7 112083.1 2015.9 0.055 
 Chemicals& Pharmaceuticals (7) 6715.4 767.5 17137.3 569.5 0.100 
Europe Electronics & Automobile (10)  47075.0 15950.3 176318.9 3003.4 0.092 
 Chemicals& Pharmaceuticals (10) 13453.4 4348.1 56984.4 1374.8 0.115 
All  29975.3 8428.7 99867.1 1874.2 0.082 
 
 Industry  
(Number of sample firms) 
ACUS USCC USOL USM 
(%) 
HOM 
(%) 
HRM 
(%) 
USR 
(%) 
USE 
(%) 
East Asia Electronics & Automobile (20) 0.032 0.003 0.028 19.4 55.7 62.8 4.6 19.3 
 Chemicals& Pharmaceuticals (7) 0.058 0.016 0.041 19.1 64.6 71.1 4.7 5.9 
Europe Electronics & Automobile (10)  0.118 0.015 0.098 22.9 17.1 48.2 9.0 6.8 
 Chemicals& Pharmaceuticals (10) 0.298 0.039 0.237 31.1 10.4 41.9 16.1 6.4 
All  0.111 0.015 0.089 22.6 42.5 56.5 8.1 12.6 
Note:  Turnover, share of sales by region and country, employees, RDE and RDI are based on the consolidated data as of 2002. 
 HOM is market share of a firm in home country;  
HRM is (market share of a firm in home region) - (market share of a firm in home country);  
USR is share of R&D personnel in US corporate R&D centers of a firm’s corporate R&D centers in the world;  
USE is share of expatriates in US corporate R&D centers of a firm. 
Sources:  USR and USE are from individual firms, patent data are from the EPO, and the rest are from company reports. 
 
 
TABLE 4 
Means, standard deviations, and correlations 
 
 1 2 3 4 5 6 7 8 9 10 
1. ACUS           
2. USCC .614***          
3. USOL .991*** .509***         
4. USM .315** .448*** .272*        
5. HOM -.551*** -.430*** -.553*** -.731***       
6. HRM -.423*** .373** -.408*** -.845*** -.856***      
7. RDE -.028 -.035 -.018 .287* -.439*** -.411***     
8. RDI .608*** .439*** .601*** .319** -.429*** -.419*** -.093    
9. USR .461*** .410** .439*** .435*** -.489*** .403** .037 .426***   
10. USE -.204 -.181 -.200 -.195 .236 .271 -.019 -.280 -.155  
Mean .111 .015 .089 .226 .425 .565 1874 .082 .081 .126 
s.d. .150 .022 .126 .127 .283 .218 1517 .050 .088 .200 
Note: *     P < .1 
**   P < .05 
*** P < .01 
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TABLE 5 
Results of ordinary least squares (OLS) analyses  
 
 Dependent variables       
 H1 H2a H2b H3 H3     
 USM USM USM USM USCC USM ACUS USCC USOL 
Independent 
variables 
 
 
  
 
      
ACUS .009 
(.045) 
        
          
USCC  
 
1.468* 
(.746) 
 1.521* 
(.774) 
     
          
USOL  
 
 .024 
(.193) 
-.060 
(.191) 
.055 
(.038) 
    
          
Sector .069 
(.045) 
.038* 
(.045) 
.071 
(.044) 
.040 
(.045) 
.202** 
(.009) 
.046 
(.050) 
.280 
(.204) 
.021* 
(.012) 
.031 
(.047) 
 
Region -.018 
(.032) 
.003 
(.039) 
-.018 
(.042) 
-.002 
(.042) 
-.011 
(.008) 
-.013 
(.044) 
-.360* 
(.177) 
-.021* 
(.010) 
.123*** 
(.041) 
 
RDE 3.376E-
05** 
(.000) 
3.062E-
05** 
(.000) 
3.403E-
05** 
(.000) 
3.060E-
05** 
(.000) 
2.254E-
06 
(.000) 
3.868E-
05** 
(.000) 
4.654E-
05 
(.000) 
3.075E-
06 
(.000) 
1.961E-
06 
(.000) 
 
RDI .522 
(.411) 
.386 
(.383) 
.524 
(.193) 
.441 
(.426) 
.054 
(.085) 
.964* 
(.479) 
3.424* 
(1.943) 
0.130 
(.114) 
1.078** 
 (.445) 
 
Adj-R2 .180 .250 .179 .233 .372 .241 .323 .293 .440 
          
 
Note: Sector (pharmaceuticals and chemicals = 0, electronics/automobile = 1). 
 Region (Europe = 0, Japan/Korea = 1). 
First row: Unstandardized coefficients. Second row: Standard errors in parenthese.  
*     P < .1; **   P < .05; *** P < .01 
TABLE 6 
Variance inflation factors (VIFs) 
 
Dependent variables Independent variables  VIF 
USM 
 
USCC 
USOL 
Sector 
Region 
RDE 
RDI 
2.162 
1.786 
1.817 
1.629 
1.378 
1.676 
 
Note:  USM, RDE and RDI are based on the consolidated data as of 2002. 
 Sector (pharmaceuticals and chemicals = 0, electronics/automobile = 1). 
 Region (Europe = 0, Japan/Korea = 1). 
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TABLE 7 
Acquisition and utilization capabilities 
(electronics/engineering & automobile industries) 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
(J = Japanese, K = Korean, D = German, C = Swiss, N = Dutch, F = Finnish, S= Swedish, E = 
electronics & engineering, A = automobiles, P = pharmaceuticals, C = chemicals) 
 
TABLE 8 
Acquisition and utilization capabilities 
 (pharmaceutical & chemical industries) 
 
  Acquisition capability (ACUS) 
  Low High 
High 1A: Market-oriented 
Canon (JE), LG (KE), 
Nissan (JA), Toyota (JA), 
BMW (DA), Volkswagen 
(DA) 
 
1B: Integrated 
Sony (JE),  Samsung (KE), 
Infenion (DE), Siemens (DE),  
Philips (NE), ABB (CE), 
Nokia (FE), Honda (JA), 
DaimlerChrysler (DA) Utilization 
capability 
(USM) 
Low 
1C: National focus 
Fuji-Xerox (JE), Hitachi (JE), 
Matsushita Electric (JE), 
NTT DoCoMo (JE), 
Sumitomo Electric (JE), 
Toshiba (JE), OKI (JE), 
Omron (JE), Bosch (DE) 
1D: Technology-oriented  
EPSON (JE), Fujitsu (JE), 
Mitsubishi Electronic (JE), 
NEC (JE), Sharp (JE), 
Ericsson (SE) 
  Acquisition capability (ACUS) 
  Low High 
High 1A:  Market-oriented 
Fujisawa (JP), 
Takeda (JP) 
 
1B:  Integrated  
Eisai (JP), Bayer (DP), 
Boehringer-Ingelheim (DP),  
Schering (DP), Novartis (CP), 
Roche (CP), Bayer (DC) Utilization 
capability 
(USM) 
Low 
1C:  National focus  
Yamanouchi (JP), 
Hitachi Chemicals (JC), 
Mitsubishi Chemicals (JC), 
Sumitomo Chemicals (JC), 
BASF (DC), Degussa (DC) 
1D:  Technology-oriented  
Merck (PC), Merck (DC) 
TABLE 9 
Combinative and independence capabilities 
(electronics/engineering & automobile industries) 
   Combinative capability (USCC) 
  Low High 
High 2A: Divided partnership  
Canon (JE), EPSON (JE),  
OKI (JE), Sharp (JE) 
 
2B: Independent-mutual partnership 
Fujitsu (JE), NEC (JE), Sony (JE), 
Samsung (KE) 
Infenion (DE), Siemens (DE), 
ABB (CE), Philips (NE) 
Ericsson (SE), Nokia (FE), Honda (JA), 
DaimlerChrysler (DA) 
Independence 
capability 
(USOL) 
Low 
2C: Paternalistic partnership 
Fuji-Xerox (JE),Hitachi (JE), 
Mitsubishi Electronic (JE), 
NTT DoCoMo (JE), Sumitomo 
Electric (JE), Toshiba (JE), LG 
(KE), Omron (JE), Nissan (JA), 
Toyota (JA), Volkswagen (DA) 
2D: Intensive partnership  
Matsushita Electric (JE) 
Bosch (DE), BMW (DA)  
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TABLE 10 
Combinative and independence capabilities 
 (pharmaceutical & chemical industries) 
  Combinative capability (USCC) 
  Low High 
High 2A: Divided partnership 
Merck (DP), Schering (DP),  
Merck (DC) 
 
2B: Independent-mutual 
partnership 
Eisai (JP), Bayer (DP), 
Boehringer-Ingelheim (DP) 
Novartis (CP), Roche (CP), 
Bayer (DC) 
Independence 
capability 
(USOL) 
Low  
2C: Paternalistic partnership  
Fujisawa (JP), Takeda (JP), 
Hitachi Chemicals (JC), 
Mitsubishi Chemicals (JC), 
Sumitomo Chemicals (JC) 
2D: Intensive partnership  
Yamanouchi (JP) 
BASF (DC), Degussa (DC) 
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